The Natural Products Association Submits Comments on Peptides
NPA is submitting comments on peptides for the FDA’s Pharmacy Compounding Advisory Committee meeting, taking place July 23–24, 2026.
NPA is submitting comments on peptides for the FDA’s Pharmacy Compounding Advisory Committee meeting, taking place July 23–24, 2026.
NPA issued a blistering statement in response to a paper from the American College of Physicians (ACP) that proposes to dismantle the U.S. regulatory framework governing dietary supplement products under the guise of protecting public health.
NPA fully supports DEA’s action targeting highly concentrated, synthetic 7-OH products and agrees with the agency that these substances pose significant risks to consumer health and safety.
NPA issued a statement in response to a study published in Nature Metabolism on the relationship between glucosamine supplementation and the accelerated progression from mild cognitive impairment to Alzheimer’s disease.
Mrs. Reinson is a highly accomplished marketing and growth executive with more than 17 years of experience driving transformational brand strategy, market expansion, thought leadership, stakeholder engagement, and revenue growth across the dietary supplement, nutraceutical, and health and wellness sectors.
Bipartisan, bicameral legislation would allow Americans to use HSAs, FSAs and HRAs for dietary supplements.
Join the VOICE of the natural products industry that represents more than 10,000 retail, manufacturing, wholesale, and distribution locations.